I will support investments and public-private partnerships to develop health care innovations, including COVID-19 vaccines and treatments for major diseases.

Clay Higgins · Louisiana · Republican

spending impact 0.70 specificity 0.65 extraction confidence 82%

Contest this claim

Occurrences

Additionally, we are working to develop new treatments and therapeutics through health care innovation. This includes the creation of a safe and effective vaccine for COVID-19 as well as ongoing research to treat and cure medical conditions like cancer, heart disease, Alzheimer’s, and others. We support investments and public-private partnerships that make these health care innovations possible.

Higgins said he supports investments and public-private partnerships to enable health care innovation, including COVID-19 vaccine development and research on treatments and cures for major diseases.

Higgins: Republicans are Working to Lower Costs, Improve Health Care - Congressman Clay Higgins
secondary · other · model gpt-5.5

Evidence

Roll Call 86 passed H.R. 6074, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020, 415-2. The vote list records Higgins (LA), Republican, Louisiana, as Yea.

Higgins voted for the initial COVID-19 emergency supplemental appropriations bill.

partial unknown

Office of the Clerk, U.S. House of Representatives - Roll Call 86, H.R. 6074
secondary · model gpt-5.5 · confidence 96%

Contest this evidence item

The law appropriated $3,100,000,000 for the Public Health and Social Services Emergency Fund for coronavirus response, including development of countermeasures and vaccines, purchase of vaccines, therapeutics, and diagnostics, manufacturing platform innovations, and contracts involving non-Federally owned facilities for vaccine, therapeutic, and diagnostic production.

The bill Higgins supported directly funded COVID-19 vaccine, therapeutic, diagnostic, and manufacturing innovation activities, matching a core part of the promise.

partial unknown

GovInfo - Public Law 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
secondary · model gpt-5.5 · confidence 94%

Contest this evidence item

Roll Call 251 on H.R. 133, concurring in the Senate amendment with amendment except Divisions B, C, E, and F, passed 359-53. The vote list records Higgins (LA), Republican, Louisiana, as Nay.

Higgins opposed a major December 2020 appropriations and COVID relief vehicle, showing his support for later pandemic-related health investments was not consistent.

never unknown

Office of the Clerk, U.S. House of Representatives - Roll Call 251, H.R. 133
secondary · model gpt-5.5 · confidence 86%

Contest this evidence item

Roll Call 72 on the American Rescue Plan Act passed 220-211. The vote list records Higgins (LA), Republican, Louisiana, as Nay.

Higgins voted against the American Rescue Plan Act, another enacted COVID-19 relief bill with vaccine and therapeutic funding provisions.

never same_term

Office of the Clerk, U.S. House of Representatives - Roll Call 72, H.R. 1319
secondary · model gpt-5.5 · confidence 95%

Contest this evidence item

The law appropriated $7,500,000,000 for COVID-19 vaccine activities, including planning, preparation, promotion, distribution, administration, monitoring, and tracking, and $500,000,000 for FDA activities on vaccines, therapeutics, diagnostics, advanced continuous manufacturing, inspections, and supply-chain oversight.

The legislation Higgins opposed contained significant vaccine, therapeutic, diagnostic, and manufacturing support, weighing against full fulfillment of a promise to support such investments.

never same_term

GovInfo - Public Law 117-2, American Rescue Plan Act of 2021
secondary · model gpt-5.5 · confidence 94%

Contest this evidence item

Assessments

partial same_term

Higgins did support at least one enacted federal investment directly aligned with the promise: he voted for the March 2020 Coronavirus Preparedness and Response Supplemental Appropriations Act, which funded vaccine, therapeutic, diagnostic, manufacturing, and public-health countermeasure work. However, his record was mixed because he later voted against major enacted COVID-19 relief and appropriations measures that also contained substantial vaccine, therapeutic, diagnostic, FDA, manufacturing, distribution, and administration funding. That supports partial credit rather than full delivery.

provider codex_cli · model gpt-5.5 · confidence 90%